synthekine.com
Get leads like Synthekine — and thousands more
Build targeted lists by tech stack, traffic, and more
Synthekine: Engineering Biology's Next Frontier
How a $289M-backed biotech is redesigning cytokines to cure cancer and inflammation
In the $200B+ immunotherapy market, most cytokines are blunt instruments—powerful but indiscriminate. Synthekine is rewriting the code of immune signaling itself, engineering hyper-selective cytokines that could finally deliver on the promise of targeted cancer and inflammation cures without the systemic toxicity.
"They're not discovering drugs—they're discovering design principles. That's the moat."
The Precision Problem
Traditional cytokines like IL-2 and IL-15 are cytokine storms waiting to happen. They activate every immune cell in sight, causing severe toxicity that has limited their clinical utility. Synthekine's breakthrough isn't in finding new cytokines—it's in re-engineering known ones to be ruthlessly selective. Their Stefan™ and Uncaria™ platforms create variants that only hit the receptors they want, when and where they want them.
Capital Efficiency Story
With 117 employees generating $18.1M in revenue, Synthekine is operating at a remarkable $155K revenue per employee for a pre-commercial biotech. This isn't burn—it's validation. Their $289M war chest (led by investors who understand platform value) gives them multiple shots on goal while maintaining lean operations. The 47% direct traffic suggests strong brand recognition in a community that doesn't just browse—it engages.
The biotech landscape is littered with companies that promised 'better cytokines.' Synthekine's differentiation is architectural: they've built two complementary platforms (Stefan for IL-2 variants, Uncaria for IL-15) that can be mixed, matched, and iterated. This isn't incremental—it's a systematic approach to solving cytokine therapeutics' fundamental paradox: potency versus safety.
- Platform-based approach vs. single-asset bets: Every molecule teaches the system something new
- Dual-platform strategy creates optionality across cancer and inflammatory disease markets
- 117-person team suggests disciplined capital allocation in an era of biotech bloat
- Strong LinkedIn presence (2,800+ followers) indicates talent magnetism in a competitive market
The Synthekine Verdict
This is a platform company disguised as a drug company. In biotech, platforms win.
What tech stack does Synthekine use?
How much traffic does Synthekine get?
Traffic & Engagement
Traffic Sources
Where is Synthekine's audience located?
What keywords does Synthekine rank for?
5 keywordsHow is Synthekine's SEO?
Meta Tags
Synthekine | Cytokines by Design
Discovering, Developing and Commercializing the Next Generation of Selective Cytokine Therapeutics. We believe that cytokine therapeutics engineered to be selective can fundamentally change the treatment paradigm of cancer and inflammatory disease.
H1 Tags
Schema Types
What is Synthekine's revenue?
Who works at Synthekine?
Loading leads...
What do customers think of Synthekine?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Synthekine
What is Synthekine's Revenue?
What does Synthekine do?
How fast is Synthekine growing?
What technologies does Synthekine use?
Who are Synthekine's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Synthekine?
Contact Information
Export synthekine.com Data
Download the complete tech stack, analytics, leads, and company data for synthekine.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About synthekine.com
Discovering, Developing and Commercializing the Next Generation of Selective Cytokine Therapeutics. We believe that cytokine therapeutics engineered to be selective can fundamentally change the treatment paradigm of cancer and inflammatory disease.
Company Overview
synthekine.com Social Media
Contact synthekine.com
Phone Numbers
Technology Stack
synthekine.com uses 20 technologies across their website including Google Fonts, HSTS, PHP, and more.
Fonts
Google Fonts
Security
HSTS
Programming Languages
PHP
CMS
WordPress
CDN
cdnjs, jsDelivr
Cloud & Hosting
Cloudflare
Traffic & Audience
synthekine.com receives approximately 4.2K monthly visitors and ranks #3,988,594 globally. The website has a bounce rate of 36% with visitors viewing an average of 2.1 pages per visit. Users spend an average of 0:30 on the site.
The majority of synthekine.com's traffic comes from .
Frequently Asked Questions
What is synthekine.com?
What technologies does synthekine.com use?
How do I contact synthekine.com?
What are synthekine.com's social media accounts?
Is synthekine.com hiring?
How popular is synthekine.com?
Related Searches
This page provides publicly available information about synthekine.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit synthekine.com directly at https://synthekine.com.